Literature DB >> 25501679

Association between HBV Pre-S mutations and the intracellular HBV DNAs in HBsAg-positive hepatocellular carcinoma in China.

Hui Wang1, Ai-Hua Wang1, Olav A Gressner2, Meng Fang1, Xing Gu1, Qiang Ji1, Shu-Qun Cheng3, Feng Shen4, Chun-Fang Gao5.   

Abstract

This study aimed to investigate the association between HBV mutations and intrahepatic HBV status and to determine the clinical features and the contribution of HBV mutations to postoperative prognosis for hepatocellular carcinoma (HCC) patients with HBsAg (+) in China. Using TaqMan fluorescent real-time PCR, HBV covalently closed circular DNA (cccDNA) and total DNA (tDNA) were both quantified in 106 pairs of tumor tissues (TT) and adjacent non-tumor tissues (ANTT) obtained from HCC patients who received no antiviral treatment before surgical treatment. The prevalence of 19 hot spot mutations was evaluated by Sanger sequencing. HBV cccDNA and tDNA were lower in TT than in ANTT. The loads of cccDNA and tDNA in ANTT were associated with serum HBV DNA and HBeAg. Three Pre-S mutants (A2962G and C2964A in Pre-S1 and C105T in Pre-S2) were associated with higher tumor cccDNA levels (P < 0.05), and A2962G/C2964A mutants were associated with higher AFP levels. This would assist to disclose the virological features, to implement a more clinically personalized therapy and to improve the prognosis of HBV-related HCC patients.

Entities:  

Keywords:  Covalently closed circular DNA; HCC; Hepatitis B virus; Pre-S; Variation

Mesh:

Substances:

Year:  2014        PMID: 25501679     DOI: 10.1007/s10238-014-0321-6

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  31 in total

1.  International trends in liver cancer incidence rates.

Authors:  Melissa M Center; Ahmedin Jemal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-15       Impact factor: 4.254

2.  Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma.

Authors:  Danny Ka Ho Wong; Fung Yu Huang; Ching Lung Lai; Ronnie Tung Ping Poon; Wai Kay Seto; James Fung; Ivan Fan Ngai Hung; Man Fung Yuen
Journal:  Hepatology       Date:  2011-07-21       Impact factor: 17.425

3.  Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma.

Authors:  Danny Ka-Ho Wong; Man-Fung Yuen; Ronnie Tung-Ping Poon; John Chi-Hang Yuen; James Fung; Ching-Lung Lai
Journal:  J Hepatol       Date:  2006-06-23       Impact factor: 25.083

4.  Comparison study on the complete sequence of hepatitis B virus identifies new mutations in core gene associated with hepatocellular carcinoma.

Authors:  Yu Zhu; Yan Jin; Xia Guo; Xin Bai; Taoyang Chen; Jinbing Wang; Gengsun Qian; John D Groopman; Jianren Gu; Jinjun Li; Hong Tu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08-10       Impact factor: 4.254

5.  Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma.

Authors:  Jianhua Yin; Jiaxin Xie; Shijian Liu; Hongwei Zhang; Lei Han; Wenying Lu; Qiuxia Shen; Guozhang Xu; Hongjun Dong; Jie Shen; Jun Zhang; Jiankang Han; Lin Wang; Yan Liu; Fan Wang; Jun Zhao; Qian Zhang; Wu Ni; Hongyang Wang; Guangwen Cao
Journal:  Am J Gastroenterol       Date:  2010-10-19       Impact factor: 10.864

Review 6.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

7.  Impact of peginterferon alpha-2b and entecavir hydrate combination therapy on persistent viral suppression in patients with chronic hepatitis B.

Authors:  Satoru Hagiwara; Masatoshi Kudo; Yukio Osaki; Hiroo Matsuo; Tadashi Inuzuka; Akihiro Matsumoto; Eiji Tanaka; Toshiharu Sakurai; Kazuomi Ueshima; Tatsuo Inoue; Norihisa Yada; Naoshi Nishida
Journal:  J Med Virol       Date:  2013-06       Impact factor: 2.327

8.  Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.

Authors:  Danny Ka-Ho Wong; Wai-Kay Seto; James Fung; Philip Ip; Fung-Yu Huang; Ching-Lung Lai; Man-Fung Yuen
Journal:  Clin Gastroenterol Hepatol       Date:  2013-02-01       Impact factor: 11.382

9.  Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus.

Authors:  J Köck; L Theilmann; P Galle; H J Schlicht
Journal:  Hepatology       Date:  1996-03       Impact factor: 17.425

Review 10.  Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden.

Authors:  V T T Nguyen; M G Law; G J Dore
Journal:  J Viral Hepat       Date:  2009-03-17       Impact factor: 3.728

View more
  2 in total

Review 1.  Management strategies for hepatocellular carcinoma: old certainties and new realities.

Authors:  Gianluigi Mazzoccoli; Roberto Tarquini; Alice Valoriani; Jude Oben; Manlio Vinciguerra; Fabio Marra
Journal:  Clin Exp Med       Date:  2015-06-16       Impact factor: 3.984

2.  Pathological changes of liver one year later in CHB patients with negative HBV DNA.

Authors:  Wu Shanshan; Du Xinfang; Yu Shuihong; Lai Kecong; Qi Jinjin; Chen Zhi; Chen Feng
Journal:  Infect Agent Cancer       Date:  2019-12-10       Impact factor: 2.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.